Abstract | PURPOSE: EXPERIMENTAL DESIGN: We developed a clinical-grade assay for formalin-fixed, paraffin-embedded (FFPE) samples using the NanoString nCounter platform to measure the mRNA expression of the previously published 12-gene set. The predictive performance was validated in a cohort of 207 patients with early-stage resected NSCLC with matched propensity score of adjuvant chemotherapy. RESULTS: CONCLUSIONS:
|
Authors | Yang Xie, Wei Lu, Shidan Wang, Ximing Tang, Hao Tang, Yunyun Zhou, Cesar Moran, Carmen Behrens, Jack A Roth, Qinghua Zhou, David H Johnson, Stephen G Swisher, John V Heymach, Vassiliki A Papadimitrakopoulou, Guanghua Xiao, John D Minna, Ignacio I Wistuba |
Journal | Clinical cancer research : an official journal of the American Association for Cancer Research
(Clin Cancer Res)
Vol. 25
Issue 1
Pg. 150-157
(01 01 2019)
ISSN: 1557-3265 [Electronic] United States |
PMID | 30287547
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
|
Copyright | ©2018 American Association for Cancer Research. |
Chemical References |
- Biomarkers, Tumor
- Neoplasm Proteins
|
Topics |
- Aged
- Antineoplastic Combined Chemotherapy Protocols
- Biomarkers, Tumor
- Carcinoma, Non-Small-Cell Lung
(drug therapy, genetics, pathology)
- Chemotherapy, Adjuvant
- Disease-Free Survival
- Female
- Gene Expression Regulation, Neoplastic
(drug effects)
- Humans
- Male
- Middle Aged
- Neoplasm Proteins
(genetics)
- Neoplasm Staging
- Paraffin Embedding
- Prognosis
- Retrospective Studies
- Risk Factors
- Transcriptome
(drug effects)
- Treatment Outcome
|